Welcome
Support Centre
11 February 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
RapTB - evaluation of techniques for tuberculosis diagnosis
ISRCTN ISRCTN79888843
ClinicalTrials.gov identifier
Public title RapTB - evaluation of techniques for tuberculosis diagnosis
Scientific title Pragmatic clinical trial and cost-effectiveness evaluation of techniques for the sensitive and resistant tuberculosis diagnosis in patients assisted at two hospitals in Rio de Janeiro - Brazil
Acronym RapTB
Serial number at source N/A
Study hypothesis The implantation of a new technology (BD960) for the tuberculosis (TB), multi-drug resistant (MDR)/TB investigation in hospital units, besides reducing the intra-hospital TB transmission and the cost of the hospitalised patients treatment, will also greatly reduce the morbid/lethality of TB patients.
Lay summary
Ethics approval Approved by the Research Ethics Committee of University Hospital Clementino Fraga Filho at the Federal University of Rio de Janeiro (ref: 020/07)
Study design Pragmatic multicentre open randomised clinical trial
Countries of recruitment Brazil
Disease/condition/study domain Tuberculosis
Participants - inclusion criteria 1. Individuals aged 18 years or more, either sex
2. Assisted in two university hospitals in the southeast area of Brazil
3. Under tuberculosis suspicion (TB)
4. With or without anti-TB treatment in the past
Participants - exclusion criteria Individuals who refuse to participate
Anticipated start date 01/08/2008
Anticipated end date 01/09/2010
Status of trial Completed
Patient information material Not available in web format, please use the contact details below to request a patient information sheet
Target number of participants 706 individuals
Interventions The diagnostic test used in the routine, the Löwenstein Jensen Proportion Method, will be compared to BACTEC™ MGIT™ 960 System.
Primary outcome measure(s) Proportion of patients for whom medical procedure is changed
after 60 days (stopping or initiating anti-TB drugs).
Secondary outcome measure(s) Patients will be followed for 180 days after randomisation. At the end of this period
we will measure:
1. Number of participants lost to follow-up
2. Number of deaths by any cause in the patients included in the study
3. Number of adverse effects to the drugs
4. Proportion of patients with TB diagnosis sensitive or resistant to anti-TB drugs
5. Proportion of patients that undergo anti-TB treatment failure during the therapy
6. Proportion of drug resistant TB development in the patients
7. Time to sensitivity determination to drugs
8. Proportion of bacteriological conversion (bacilloscopy and culture for mycobacterium) due to the anti-TB treatment at the end of the second and sixth month of anti-TB treatment
9. Cost of the pulmonary TB diagnostic test, for each test, and for the anti-TB treatment
10. Cost of the resistant pulmonary TB diagnostic test for each test and for the anti-TB treatment
11. Cost for the patient and family nucleus in relation to the TB diagnosis
12. Cost for the public health system (SUS) in relation to the TB diagnosis
13. Proportion of necessary human resources for the accomplishment of the TB diagnostic
test
14. Proportion of necessary human resources for the resistant TB diagnostic test
Sources of funding Brazilian Ministry of Health/UNESCO (Brazil) - Pragmatic Diagnostic Trials on TB (ref: 914BRA2000 - DECIT PRODOC, Processo FUJB no. 11.125-2)
Trial website
Publications 2008 Conference proceedings (abstract in Portugese)
Rapid-TB - A pragmatic clinical trial to evaluate cost-effectiveness of diagnostic tests for tuberculosis: MGIT vs LJ. (Rapid-TB - Um ensaio clínico pragmático para
avaliação de custo-efetividade dos testes diagnósticos em tuberculose: MGIT vs L-J)
Rezende, AS; Castro, CBA; AguirR, FS; Marsico AG; Costa, PA; Vieira, Mams; Vieira,
GBO; Fonseca, LS; Huf G; Kritski AL. 3rd National Meeting on Tuberculosis, Salvador. Jornal Brasileiro de Pneumologia. 2008. v.34. p.21 – 21.
Contact name Dr  Gisele  Huf
  Address INCQS - Instituto Nacional de Controle em Qualidade de Saúde
Av. Brasil, 4365 - Manguinhos
  City/town Rio de Janeiro
  Zip/Postcode 21.040-900
  Country Brazil
Sponsor Brazilian Tuberculosis Research Network (Rede Brasileira de Pesquisa em Tuberculose [REDE-TB]) (Brazil)
  Address Av. Carlos Chagas Filho,
791 - Cidade Universitária,
Ilha do Fundão
  City/town Rio de Janeiro
  Zip/Postcode 21941-904
  Country Brazil
  Sponsor website: http://www.redetb.org
Date applied 05/05/2009
Last edited 07/01/2010
Date ISRCTN assigned 07/01/2010
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central